Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies

View source ↗

Summary

The study aims to establish organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Head and Neck Cancer | Status: RECRUITING